Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy

Stanford University logo

Stanford University

Status

Terminated

Conditions

Prostate Cancer

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02432820
IRB-33012
PROS0070 (Other Identifier)

Details and patient eligibility

About

SPECIFIC STUDY AIMS To evaluate congruence between pelvic anatomical structures segmented on MRI and/or CT scans co-registered with transperineal US scans acquired with an optically and/or electromagnetically tracked matrix array ultrasound transducer. To estimate the achievable accuracy of anatomy tracking based on 3D US matrix-array transducer imaging and grey-level based image registration algorithms.

Full description

SPECIFIC STUDY AIMS To evaluate congruence between pelvic anatomical structures segmented on MRI and/or CT scans co-registered with transperineal US scans acquired with an optically and/or electromagnetically tracked matrix array ultrasound transducer. To estimate the achievable accuracy of anatomy tracking based on 3D US matrix-array transducer imaging and grey-level based image registration algorithms.

Enrollment

7 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men that will undergo prostate radiotherapy as a primary treatment or post-prostatectomy.
  • Age 18 or older
  • Ability to understand and sign informed consent

Exclusion criteria

  • Younger than 18 yrs old
  • Inability to provide written and spoken consent.
  • Patients with implanted actively controlled devices that may be subject to electromagnetic interference from the UroNav/PervuNav electromagnetic tracking used in the study.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems